Related Experiment Video
Updated: Jul 3, 2026
11:34
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
[The patient with uncontrolled chronic hepatitis B]
1Clinique Universitaire d'Hépato-Gastroentérologie, Pôle DIGI-DUNE, Centre de recherche INSERM-UJF U823 IAPC, CHU de Grenoble, BP 217, 38043 Grenoble cedex, France. JPZarski@chu-grenoble.fr
Gastroenterologie Clinique Et Biologique
|July 30, 2008
Summary
Effective chronic hepatitis B treatment involves pegylated interferon or nucleoside/nucleotide analogs. Regular monitoring of hepatitis B virus (HBV) DNA levels is crucial for managing treatment efficacy and preventing resistance.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Context:
- Chronic hepatitis B treatment relies on pegylated interferon or nucleoside/nucleotide analogs.
- Current therapies aim to control viral replication and achieve hepatitis B virus (HBV) DNA negativation.
Purpose:
- To outline current treatment strategies for chronic hepatitis B.
- To emphasize the importance of monitoring viral load and managing drug resistance.
Summary:
- Antiviral therapy for chronic hepatitis B involves pegylated interferon or nucleoside/nucleotide analogs, achieving viral suppression in most cases.
- Treatment modification, including combination therapy with nucleoside and nucleotide analogs, is necessary for primary non-response or emerging resistance.
- Regular HBV DNA monitoring every three months using sensitive methods like Real Time PCR is essential for assessing treatment efficacy and preventing rebounds.
Impact:
- Optimized treatment regimens can improve patient outcomes in chronic hepatitis B management.
- Proactive monitoring strategies help mitigate the risk of antiviral resistance and clinical deterioration.
- Understanding treatment response dynamics guides clinical decision-making for sustained viral control.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...